基于Meta分析的生脉注射液治疗冠心病心绞痛系统评价

目的:系统评价生脉注射液治疗冠心病心绞痛的有效性及安全性。方法:计算机检索中国期刊全文数据库CNKI,万方数据库,维普数据库VIP,Pub Med和Cochrane Library等数据库,全面收集生脉注射液治疗冠心病心绞痛的随机对照试验(RCT)的文献。采用Cochrane风险评价表进行文献质量评价,运用Revman 5.2软件进行Meta分析。结果:共纳入14项随机对照试验,共包括932例患者,其中实验组472例,对照组460例。Meta分析结果显示,在西医常规治疗的基础上,生脉注射液治疗冠心病心绞痛的临床疗效总有效率高于对照组,组间差异有统计学意义RR=1.24,95%CI(1.17,1.32),P0.000 01];在西医常规治疗的基础上,联合使用生脉注射液可以有效降低高敏C反应蛋白水平,差异具有统计学意义MD=-4.46,95%CI(-6.79,-2.12),P=0.000 2];在西医常规治疗的基础上,联合使用生脉注射液可以有效降低血浆黏度,差异具有统计学意义MD=-0.11,95%CI(-0.18,-0.03),P=0.006]。结论:生脉注射液用于治疗冠心病心绞痛具有较好疗效。

Systematic Evaluation on Shengmai Injection in Treatment of Angina Pectoris in Coronary Heart Disease

Objective: To systematically evaluate the clinical efficacy and safety of Shengmai injection in the treatment of angina pectoris in coronary heart disease. Method: Literatures concerning randomized controlled trials(RCTs) regarding Shengmai injection in the treatment of angina pectoris in coronary heart disease were searched in CNKI, VIP, WanFang Database, CBM, PubMed, Embase and Cochrane Library. Quality of the included studies was evaluated with the method recommended in Cochrane, extracted the required information, and statistical was performed using the Review Manager 5.2 software. Result: A total of 14 RCTs with 932 participants were included, and the experimental group was 472 cases and the control group was 460 cases. Clinical effect analysis:Firstly, 9 studies included compare the total clinical effective rate, the Meta-analysis indicated that Shengmai injection combined with conventional treatment with western medicine is effective in treating angina pectoris in coronary heart disease, on the basis of conventional therapy, Shengmai injection's total clinical effective rate is higher compared to the control group, there were statistically significant differences between groupsRR=1.24, 95%CI(1.17,1.32), P<0.00001]. Secondly, 3 studies compared Hs-CRP and the Meta-analysis indicated that Shengmai injection combined with conventional treatment with western medicine can reduce Hs-CRP effectivelyMD=-4.46, 95%CI(-6.79,-2.12), P=0.0002]. Finally, 2 studies compared the rheology of blood and the Meta-analysis indicated Shengmai injection combined with conventional treatment with western medicine can reduce rheology of blood effectivelyMD=-0.11, 95%CI(-0.18,-0.03),P=0.006]. Conclusion: Shengmai injection combined with conventional treatment with western medicine is effective in treating cardiovascular and cerebrovascular diseases.